百合医疗Baihe品牌怎么样 申请店铺

更新时间:2024-10-28
百合医疗Baihe是哪个国家的品牌?「百合医疗Baihe」是 广东百合医疗科技股份有限公司 旗下著名品牌。该品牌发源于广东省佛山市,由创始人黄 *在1999年期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。
百合医疗Baihe怎么样

广东百合医疗科技股份有限公司,创办于1999年,位于佛山市南海区狮山镇桃园东路89号。公司主营业务为一次性使用医用耗材等医疗器械的研发、生产和销售,是一家现代工程技术和临床医学相结合的企业,是国内高端医用耗材领域能够与国外产品形成强有力竞争的为数不多的企业之一。

公司拥有国内先进的医用耗材生产工艺和技术,完善的质量保证体系,现代化的管理手段以及高品质的产品和优质的服务。从公司创立之初的中心静脉导管和血液透析导管起步,截止目前,公司已经形成静脉输液耗材、血液净化耗材、护创敷料耗材三大领域,并依托三大领域的技术优势和丰富的产品储备,成为上述领域内的一次性使用医用耗材综合解决方案提供商。

公司聚集了由陈建华等医用耗材专家领衔的高水平专业研发和技术创新团队,人才储备充足,专业涵盖医用高分子材料、生物医学工程、临床医学、检验医学、生命科学、生物化学、材料学、模具、机械等多个学科。公司主要产品有:中心静脉导管、血液透析导管、输液接头、延长管、旋塞、留置针、血液回路、内瘘穿刺包、压力传感器等三类医疗器械。

产品已经销往世界各地,其中中心静脉导管及血液透析导管两个主导产品国内市场占有率均较高。

公司获得包括华南理工大学、暨南大学、中山大学附属医院、南方医科大学珠江医院等院校及各级政府机构和社会各界的关注和支持,使得百合医疗对医用导管产品的基础研究和临床试用得以顺利开展,并取得长足进步。

公司将继续秉承“注重信誉,对生命负责;追求卓越,让顾客满意”的价值观,坚持以“用户为中心”的设计理念,继续致力于一次性使用医用耗材等医疗器械的研发、生产和销售。公司将本着“为患者负责”的精神,精益求精,争取早日跻身世界领先的一次性使用医用耗材综合解决方案提供商行列。


Guangdong Baihe Medical Technology Co., Ltd., founded in 1999, is located at No. 89, Taoyuan East Road, Shishan town, Nanhai District, Foshan City. The main business of the company is the research and development, production and sales of disposable medical consumables and other medical devices. It is an enterprise combining modern engineering technology and clinical medicine, and one of the few enterprises in the domestic high-end medical consumables field that can form strong competition with foreign products. The company has advanced production technology and technology of medical consumables, perfect quality assurance system, modern management means, high-quality products and high-quality services. From the beginning of the company's establishment, the central venous catheter and hemodialysis catheter started. Up to now, the company has formed three major fields: intravenous infusion consumables, blood purification consumables and nursing wound dressing consumables. Relying on the technical advantages and rich product reserves of the three fields, the company has become a comprehensive solution provider of disposable medical consumables in the above fields. The company has gathered a high-level professional R & D and technical innovation team led by Chen Jianhua and other medical consumables experts, with sufficient talent reserve, covering medical polymer materials, biomedical engineering, clinical medicine, laboratory medicine, life science, biochemistry, materials science, mold, machinery and other disciplines. The company's main products are: central venous catheter, hemodialysis catheter, infusion connector, extension tube, cock, indwelling needle, blood circuit, internal fistula puncture bag, pressure sensor and other three types of medical devices. The products have been sold all over the world, and the two leading products of central venous catheter and hemodialysis catheter have a high market share in China. The company has obtained the attention and support from colleges and universities including South China University of technology, Jinan University, Affiliated Hospital of Sun Yat sen University, Pearl River Hospital of Southern Medical University, as well as government agencies at all levels and all sectors of the society, which makes Lily medical carry out the basic research and clinical trial of medical catheter products smoothly and make great progress. The company will continue to adhere to the values of "pay attention to reputation, be responsible for life; pursue excellence, make customers satisfied", adhere to the design concept of "user centered", and continue to be committed to the research, development, production and sales of disposable medical consumables and other medical devices. In the spirit of "being responsible for patients", the company will strive for perfection and become one of the world's leading providers of comprehensive solutions for disposable medical consumables as soon as possible.

本文链接: https://brand.waitui.com/c48592003.html 联系电话:0757-66884888,81207300

千城特选小程序码

7×24h 快讯

“灵生科技”获千万级天使轮融资

36氪获悉,专注具身智能的“灵生科技”近日宣布完成千万级天使轮融资,投资方包括天容海色、万物为创投、夸克电力。融资资金将用于灵生类脑产品线研发。

37分钟前

康斯特:预计明年设备更新政策会逐步产生落地效果

康斯特在业绩说明会上表示,针对美国大选落地后加税程度存在一定不确定性,新加坡公司已全力加强建设,计划在明年1月中旬前,非美国市场的订单全部由新加坡子公司管理;国内市场方面,三季度的订单会对四季度的业绩形成一定助力,但低价竞争仍是主要问题,今年二季度陆续出台的产业政策目前体感有限,设备更新政策对仪表行业的规模增长有一定的迟滞期,预计明年会逐步产生落地效果。(证券时报)

37分钟前

沪深两市成交额突破1.5万亿元

36氪获悉,截至发稿,沪深两市成交额突破1.5万亿元,较上一交易日此时放量超600亿元。

37分钟前

阿里影业接盘华谊兄弟所持东阳美拉70%股份

36氪获悉,企查查App显示,近日,浙江东阳美拉传媒有限公司发生工商变更,华谊兄弟退出股东,退出前持股70%,新增北京阿里巴巴影业文化有限公司为股东,同时公司法定代表人由王忠磊变更为李捷。企查查信息显示,该公司成立于2015年,注册资本500万元人民币,经营范围包含:影视文化信息咨询;影视剧本创作、策划、交易等。

37分钟前

多家钢企酝酿并购重组,中钢协将出台鼓励政策

“很多企业在考虑强强联手,并购重组。”中国钢铁工业协会(以下简称“中钢协”)副秘书长兼产业运行部主任陈玉千透露,“行业内有不少优势企业有能力且有意愿通过主动探索重组,来争取新的发展机遇。”他同时透露,中钢协正在组织行业力量,根据企业提出的意见深入研究,并提出有针对性和可操作性的支持政策。(中国经营报)

37分钟前

本页详细列出关于百合医疗Baihe的品牌信息,含品牌所属公司介绍,百合医疗Baihe所处行业的品牌地位及优势。
咨询